Bactiguard continues cooperation with the Swedish counties Kronoberg and Blekinge

Bactiguard has won a tender for urinary catheters covering the two Swedish counties Kronoberg and Blekinge. The contract is an extension of the previous agreement for 2 (+2)years which enable healthcare providers to purchase Bactiguard anti-infective urinary catheters.

"This specific region has been using our products since 2012 and has now recently decided to continue the use of our catheters also during the next contract period. We have a very good cooperation and welcome their renewed trust in us delivering infection prevention to the region,” says Nina Nilsson, Director of Marketing at Bactiguard. She continues:

“The need to include anti-infective products in the procurement range is constantly increasing. From October 1 onwards, our products will be available in Halland Region and from November 1 in the Värmland County Council. In addition to the Kronoberg Region and Blekinge County Council, our products have also been procured by Kalmar County Council.”

For further information, please contact:

Nina Nilsson, Director of Marketing, mobile: +46 70 214 87 49

About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, South America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at

About Us

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large. The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner BD, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract. Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. Recently, Bactiguard completed the acquisition of Malaysian Vigilenz, a manufacturer and supplier of medical devices and consumables, primarily within wound care and infection prevention. Following the acquisition, Bactiguard has about 180 employees around the world. Its headquarters and one of three production facilities are located in Stockholm, the other two in Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at


Documents & Links